Skip to main content
. 2022 Jan 27;29(2):551–564. doi: 10.3390/curroncol29020050

Figure 3.

Figure 3

Proposed treatment algorithm for intrahepatic cholangiocarcinoma patients, according to available evidence. Abbreviations: CDDP: cisplatin; FGFR: Fibroblast Growth Factor Receptor inhibitors; GEM: gemcitabine; ICIs: immune checkpoint inhibitors; IDHi: Isocitrate Dehydrogenase inhibitors.